Blueprint Medicines Corp (BPMC)
129.46
0.00 (0.00%)
USD |
NASDAQ |
Aug 13, 16:00
Blueprint Medicines Debt to Equity Ratio
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2025 | 2.085 |
| December 31, 2024 | 2.425 |
| September 30, 2024 | 2.340 |
| June 30, 2024 | 2.312 |
| March 31, 2024 | 1.925 |
| December 31, 2023 | 5.927 |
| September 30, 2023 | 3.821 |
| June 30, 2023 | 2.172 |
| March 31, 2023 | 1.629 |
| December 31, 2022 | 1.307 |
| September 30, 2022 | 1.043 |
| June 30, 2022 | 0.3729 |
| March 31, 2022 | 0.1242 |
| December 31, 2021 | 0.1148 |
| September 30, 2021 | 0.0672 |
| June 30, 2021 | 0.0645 |
| March 31, 2021 | 0.0626 |
| December 31, 2020 | 0.061 |
| September 30, 2020 | 0.0692 |
| June 30, 2020 | 0.1602 |
| March 31, 2020 | 0.1389 |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2066 |
| September 30, 2019 | 0.1888 |
| June 30, 2019 | 0.167 |
| March 31, 2019 | 0.2894 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.0006 |
| June 30, 2018 | 0.0013 |
| March 31, 2018 | 0.0019 |
| December 31, 2017 | 0.0024 |
| September 30, 2017 | 0.0061 |
| June 30, 2017 | 0.0071 |
| March 31, 2017 | 0.0172 |
| December 31, 2016 | 0.0191 |
| September 30, 2016 | 0.05 |
| June 30, 2016 | 0.0507 |
| March 31, 2016 | 0.0503 |
| December 31, 2015 | 0.051 |
| September 30, 2015 | 0.0498 |
| June 30, 2015 | 0.0487 |
| March 31, 2015 | 0.3663 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agenus, Inc. | -1.458 |
| Amgen, Inc. | 4.903 |
| Altimmune, Inc. | 0.076 |
| Amarantus Bioscience Holdings, Inc. | -- |
| Aligos Therapeutics, Inc. | 0.1099 |